Literature DB >> 6355313

Recombinant DNA risk assessment studies in humans: efficacy of poorly mobilizable plasmids in biologic containment.

M M Levine, J B Kaper, H Lockman, R E Black, M L Clements, S Falkow.   

Abstract

Recombinant DNA risk assessment studies quantitated the mobilizability of "safe" plasmid pBR325, in comparison with readily mobilizable plasmid pJBK5 (chloramphenicol and tetracycline resistant). Of 15 volunteers who became colonized after ingestion of 5 X 10(10) Escherichia coli HS-4, a normal human flora strain containing pJBK5 and daily oral tetracycline, nine manifested transfer of pJBK5 to normal flora by means of triparental mating. In contrast, none of 12 other volunteers cocolonized with HS-4 bearing "safe" pBR325 and normal flora showed transfer (P = 0.001), despite ingestion of tetracycline. To accomplish transfer directly, E coli HS-4 containing both pBR325 and a derepressed, conjugative plasmid (F-amp) was fed to two groups of volunteers. Transfer of pBR325 to normal flora occurred in 13 of 18 volunteers taking daily tetracycline but in none of eight who did not (P less than 0.002). Nor were transconjugants detected, despite tetracycline ingestion, in five volunteers who ingested and excreted E coli K12 (pBR325 plus F-amp).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6355313     DOI: 10.1093/infdis/148.4.699

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Diminished immunogenicity of a recombination-deficient derivative of Vibrio cholerae vaccine strain CVD103.

Authors:  J M Ketley; J B Kaper; D A Herrington; G Losonsky; M M Levine
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

2.  Inhibition of macrophage phagosome-lysosome fusion by Salmonella typhimurium.

Authors:  N A Buchmeier; F Heffron
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

3.  Enterotoxin and cytotoxin production by enteroinvasive Escherichia coli.

Authors:  A Fasano; B A Kay; R G Russell; D R Maneval; M M Levin
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

Review 4.  Mosquitocidal toxins of bacilli and their genetic manipulation for effective biological control of mosquitoes.

Authors:  A G Porter; E W Davidson; J W Liu
Journal:  Microbiol Rev       Date:  1993-12

5.  Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation.

Authors:  K G Jarvis; J A Girón; A E Jerse; T K McDaniel; M S Donnenberg; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

6.  Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors.

Authors:  Chee-Mun Fang; Jin Yuan Wang; Magaly Chinchilla; Myron M Levine; William C Blackwelder; James E Galen
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

7.  A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar Typhi live vectors.

Authors:  James E Galen; Jin Yuan Wang; Magaly Chinchilla; Christopher Vindurampulle; Jeffrey E Vogel; Haim Levy; William C Blackwelder; Marcela F Pasetti; Myron M Levine
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

8.  Plasmid and chromosomal elements involved in the pathogenesis of attaching and effacing Escherichia coli.

Authors:  A E Jerse; K G Gicquelais; J B Kaper
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

9.  Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.

Authors:  M M Levine; D Herrington; J R Murphy; J G Morris; G Losonsky; B Tall; A A Lindberg; S Svenson; S Baqar; M F Edwards
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

10.  Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro.

Authors:  A Fasano; F R Noriega; D R Maneval; S Chanasongcram; R Russell; S Guandalini; M M Levine
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.